Imaging in Cancer Drug Development
14th March - 15th March 2012 | UK
Category: R&D
Address: Copthorne Tara Hotel, London, W8 5SR, UK
Organiser: SMi Group
Website: CLICK HERE to open.Join SMi at their 8th annual Imaging in Cancer Drug Development conference where you will hear and learn from industry experts on the current best practices and correct use of imaging modalities and how you can improve the efficiency of your drug development processes.
Hear from our expert speakers, including:
Werner Scheuer, Research Leader Preclinical Imaging, Roche Diagnostics
Yanping Luo, Group Leader Translational Imaging, Abbott
Peter Eggelton, Medical Director Oncology, Merck
Paul McSheehy, Director Oncology, Novartis
Anthony M Giamis, Head of Radiochemistry, Abbott
Christopher Foley, Imaging Manager, GlaxoSmithKline
Simon Walker-Samuel, Senior Research Associate, University College London
Gabriela Grigorean, Co-Ordinator, Mass Spectrometry Unit, European Institute of Oncology
Francois Lassailly, In-vivo Imaging Specialist, Cancer Research UK
Benefits of attending
• Hear firsthand accounts of the most recent research in the field
• See how industry leaders are using the latest technology in commercial settings
• Review the latest in regulatory guidelines from European and US experts
• Hear new innovative technological developments
• Discuss preventative measures in drug failures
• Understand the potential value of your product
• Explore opportunities in partnerships
PLUS AN INTERACTIVE PRE-CONFERENCE WORKSHOP ON
Tuesday 13th March 2012, The Grange Holborn, London
8:30 am – 12:30 pm
Can Molecular Imaging Reduce the Cost of Drug Development?
Led by William Hallett, Imanova
To register today please visit http://www.smi-online.co.uk/cancer-imaging29.asp
Alternatively contact Andrew Gibbons on tel: +44 (0) 20 7827 6156 or email: agibbons@smi-online.co.uk
